Skip to main content
Erschienen in: Psychiatric Quarterly 2/2018

22.12.2017 | Original Paper

Comparison of the Adult ADHD Self Report Scale Screener for DSM-IV and DSM-5 in a Dually Diagnosed Correctional Population

verfasst von: Leo Bastiaens, James Galus

Erschienen in: Psychiatric Quarterly | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

The diagnosis of Attention Deficit Hyperactivity Disorder in adults with Substance Use Disorders is complicated. A specific screening tool, such as the World Health Organization Adult ADHD Self Report Scale Screener can be the first step in identifying the condition. Recently, the screener has been revised because the Diagnostic and Statistical Manual of Mental Disorders, Fifth edition, made some changes to the criteria for Attention Deficit Hyperactivity Disorder. This study compared the screeners based upon the Fourth and Fifth edition of the Manual. One hundred and forty patients, including seventy with Attention Deficit Hyperactivity Disorder, completed both screeners, independent from a clinical diagnostic interview. The sensitivity, specificity, and predictive values were calculated based on four different scoring methods: a categorical score of three or four positive answers, and a dimensional score of twelve or fourteen. Both screening instruments appeared to perform equally without significant differences between them, no matter which scoring system was used. However, the only satisfactory result was obtained using the dimensional scoring with a cutoff of 12, providing a sensitivity and negative predictive value above 80%. This is a lower cut off than recommended in community and clinic samples. It is possible that the cut off of the screener may need to be adjusted depending on the circumstances within which it is used.
Literatur
1.
Zurück zum Zitat Simon V, Czobor P, Balint S. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009;194:204–11.CrossRefPubMed Simon V, Czobor P, Balint S. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009;194:204–11.CrossRefPubMed
2.
Zurück zum Zitat Van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend. 2012;122:11–9.CrossRefPubMed Van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend. 2012;122:11–9.CrossRefPubMed
3.
Zurück zum Zitat Kessler R, Berglund P, Demler O. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602.CrossRefPubMed Kessler R, Berglund P, Demler O. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602.CrossRefPubMed
4.
Zurück zum Zitat Schubiner H. Substance abuse in patients with attention-deficit hyperactivity disorder. CNS Drugs. 2005;19:643–55.CrossRefPubMed Schubiner H. Substance abuse in patients with attention-deficit hyperactivity disorder. CNS Drugs. 2005;19:643–55.CrossRefPubMed
5.
Zurück zum Zitat Wilens T. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am. 2004;27:283–301.CrossRefPubMed Wilens T. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am. 2004;27:283–301.CrossRefPubMed
6.
Zurück zum Zitat Kessler R, Adler L, Ames M, et al. The World Health Organization adult ADHD self report scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35:245–56.CrossRefPubMed Kessler R, Adler L, Ames M, et al. The World Health Organization adult ADHD self report scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35:245–56.CrossRefPubMed
7.
Zurück zum Zitat Kessler R, Adler L, Gruber M, et al. Validity of the World Health Organization adult ADHD self-report scale (ASRS) screener in a representative sample of health plan members. Int J Methods Psychiatr Res. 2007;16:52–65.CrossRefPubMedPubMedCentral Kessler R, Adler L, Gruber M, et al. Validity of the World Health Organization adult ADHD self-report scale (ASRS) screener in a representative sample of health plan members. Int J Methods Psychiatr Res. 2007;16:52–65.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Daigre C, Ramos-Quiroga JA, Valero S, Adult ADHD. Self report scale (ASRS-v1.1) symptom checklist in patients with substance use disorders. Actas Esp Psiquiatr. 2009;37:299–305. Daigre C, Ramos-Quiroga JA, Valero S, Adult ADHD. Self report scale (ASRS-v1.1) symptom checklist in patients with substance use disorders. Actas Esp Psiquiatr. 2009;37:299–305.
9.
Zurück zum Zitat Van de Glind G, van den Brink W, Koeter MWJ. Validity of the adult ADHD self report scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug Alcohol Depend. 2013;132:587–96.CrossRefPubMedPubMedCentral Van de Glind G, van den Brink W, Koeter MWJ. Validity of the adult ADHD self report scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug Alcohol Depend. 2013;132:587–96.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Chiasson JP, Stavro K, Rizkallah E. Questioning the specificity of the ASRS-v1.1 to accurately detect ADHD in substance abusing populations. J Atten Disord. 2012;16:661–3.CrossRefPubMed Chiasson JP, Stavro K, Rizkallah E. Questioning the specificity of the ASRS-v1.1 to accurately detect ADHD in substance abusing populations. J Atten Disord. 2012;16:661–3.CrossRefPubMed
11.
Zurück zum Zitat Ustun B, Adler L, Rudin C. The World Health Organization adult attention-deficit/hyperactivity disorder self-report screening scale for DSM-5. JAMA Psychiat. 2017;74:520–6.CrossRef Ustun B, Adler L, Rudin C. The World Health Organization adult attention-deficit/hyperactivity disorder self-report screening scale for DSM-5. JAMA Psychiat. 2017;74:520–6.CrossRef
12.
Zurück zum Zitat Prince JB, Wilens TE, Biederman J. A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2004;10:193–204.CrossRef Prince JB, Wilens TE, Biederman J. A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2004;10:193–204.CrossRef
Metadaten
Titel
Comparison of the Adult ADHD Self Report Scale Screener for DSM-IV and DSM-5 in a Dually Diagnosed Correctional Population
verfasst von
Leo Bastiaens
James Galus
Publikationsdatum
22.12.2017
Verlag
Springer US
Erschienen in
Psychiatric Quarterly / Ausgabe 2/2018
Print ISSN: 0033-2720
Elektronische ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-017-9553-4

Weitere Artikel der Ausgabe 2/2018

Psychiatric Quarterly 2/2018 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.